Novavax, healthcare, covid, omicron, vaccine, American stock, healthcare stock, nasdaq, nyse

Are Novavax’s protein technology Covid shots & omicron-fighting prototype worth Investing : Novavax, Inc. (NASDAQ: NVAX) ?

Novavax, Inc (NASDAQ: NVAX) is a biotechnology company committed to help address serious infectious disease globally through the discovery, development, and delivery of innovative vaccines to patients around the world. The company works in the clinical stage of development with…

Similar Posts